Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Mahachai Hospital Public Company Limited operates a network of healthcare facilities in Thailand, primarily serving the Samut Sakhon province. The hospital's competitive position is bolstered by its comprehensive range of medical services, including specialized care in cardiology and orthopedics, which cater to the growing demand for quality healthcare in the region.
Mahachai Hospital generates revenue primarily through inpatient and outpatient services, leveraging its established reputation and strategic location to attract patients. The hospital benefits from pricing power due to its specialized services and high-quality care, which are critical in a competitive healthcare landscape.
Changes in healthcare regulations impacting reimbursement rates
Patient volume fluctuations due to regional health trends
Innovations in medical technology and service offerings
Economic conditions affecting consumer spending on healthcare
Regulatory changes in healthcare that could affect reimbursement rates
Technological disruption leading to new treatment modalities
Emergence of new healthcare providers in the region
Price competition from other hospitals and clinics
High debt levels (Debt/Equity ratio of 2.84) could strain financial flexibility
Low current ratio (0.49) indicates potential liquidity issues
moderate - the hospital's performance is somewhat linked to GDP growth and consumer spending, as economic downturns may lead to reduced discretionary spending on healthcare services.
Interest rates affect the hospital's financing costs for capital expenditures and expansion projects, potentially impacting profitability and valuation multiples.
minimal - the hospital is not heavily reliant on credit for operations, but high debt levels could pose risks if credit conditions tighten.
value - the low Price/Sales ratio (0.5x) and high free cash flow yield (35.7%) may attract value-focused investors.
moderate - historical volatility is expected to be moderate due to the stable nature of healthcare demand.